[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351412-105":59,"doc-detail-351412-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","transcriptomic-profiles-from-normal-and-tumor-tissue-samples-reveal-distinct-venule-populations-and-novel-tumor-endothelial-cell-markers-in-breast-cancer-research-article-summary","Transcriptomic profiles from normal and tumor tissue samples reveal distinct venule populations and novel tumor endothelial cell markers in breast cancer - Research article summary","","Background: The breast tumor microenvironment contains complex factors driving breast cancer heterogeneity and treatment resistance, and abnormal tumor vasculature restricts nutrient and drug delivery while impairing anti-tumor immunity. Methods: Publicly available scRNA-seq datasets were integrated, and endothelial-cell subsets were extracted, clustered, and compared between normal and tumor tissues, with validation across multiple single-cell resources. Results: Tumor endothelial cells showed venule-dominant, anergy-like phenotypes and TEC-specific markers, including a novel vascular marker ADM5 linked to poor patient survival. Conclusions: These TEC markers and pathways suggest opportunities to therapeutically target or reactivate anergic tumor endothelium.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/transcriptomic-profiles-from-normal-and-tumor-tissue-samples-reveal-distinct-venule-populations-and-novel-tumor-endothelial-cell-markers-in-breast-cancer-research-article-summary/351412/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/transcriptomic-profiles-from-normal-and-tumor-tissue-samples-reveal-distinct-venule-populations-and-novel-tumor-endothelial-cell-markers-in-breast-cancer-research-article-summary/351412.png","ImageObject",300,407,{"name":92,"@type":93},"Alex Sinclair","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main purpose of comparing normal and tumor endothelial cells in this study?","Question",{"text":113,"@type":114},"To characterize how endothelial-cell populations differ between normal breast tissue and breast tumors, identify tumor endothelial subtypes, and uncover tumor-specific vascular therapeutic targets.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were endothelial-cell subtypes and tumor-specific markers identified?",{"text":118,"@type":114},"Single-cell RNA-seq datasets were integrated, endothelial subsets were extracted using canonical marker expression, then cells were clustered and differentially expressed genes were determined between normal and tumor endothelial cells.",{"name":120,"@type":111,"acceptedAnswer":121},"Which marker is highlighted as novel, and what clinical association is reported?",{"text":122,"@type":114},"ADM5 is presented as a novel tumor vascular marker enriched in tumor venules; high ADM5 expression is associated with reduced patient survival, including in certain treatment contexts and breast cancer subtypes.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},351412,1790161921,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Phoenix et al. Breast Cancer Research (2026) 28:69 Breast Cancer Research  \n[https://doi.org/10.1186/s13058-026-02249-0](https://doi.org/10.1186/s13058-026-02249-0)  \nRESEARCH Open Access  \nTranscriptomic profiles from normal and tumor tissue samples reveal distinct venule populations and novel tumor endothelial cell markers in breast cancer  \nKathryn N. Phoenix 1,2, Vijender Singh2,3, Patrick A. Murphy 1 and Kevin P. Claffey 1*  \nAbstract  \nBackground The breast tumor microenvironment (TME) is a complex milieu composed of many factors contributing to breast cancer (BC) heterogeneity and therapeutic resistance. Aberrant tumor vasculature in theTME limits nutrient and drug delivery, inhibits anti-tumor immunity, and contributes to a lack of cancer therapy efficacy. Utilizing publicly available scRNA-seq datasets, this study characterizes differences between normal breast and breast tumor endothelial cells (EC), provides insights into tumor endothelial cell subtypes, endothelial anergy, and identifies novel, tumor-specific vascular therapeutic targets.  \nMethods Gene expression data from normal and breast tumor tissue samples were integrated, and the EC subset was extracted via canonical gene marker expression. The EC subset was clustered and evaluated for cell subtypes and differentially expressed genes (DEG) . Normal EC (NEC) and tumor EC (TEC) markers were further assessed for correlation to bulk gene expression and patient survival outcomes in cBioPortal and Kaplan–Meier Plotter. Cell type gene expression specificity was evaluated in the 3CA single-cell RNA-seq datasets across multiple cancers.  \nResults This analysis revealed differences in NEC and TEC subtype populations. Breast NEC contained similar proportions of venule and capillary populations, while breast TEC demonstrated a majority of the venule subtype. Further, TEC venules were phenotypically distinct from the NEC venules. Consistent with endothelial anergy, suppression of the key adhesion protein SELE was noted, as well as several pro-inflammatory cytokines including IL6, CCL2, and CXCL8, likely downstream of aberrant NF-kB signaling. Differential gene expression analysis identified several TEC specific up-regulated genes compared to NEC, including CLEC14a, IGFBP4, EMCN, and ADM5 . CLEC14a, EMCN, and ADM5 were further validated in the single-cell Curated Cancer Cell Atlas (3CA) to be highly specific to the endothelial cell clusters across multiple tumor types, while IGFBP4 was diversely expressed in endothelial, fibroblast, and some malignant cell types. ADM5, a novel tumor vascular marker, was enhanced in TEC venules and less so in arteriole or capillaries. High expression of ADM5 was associated with poor breast cancer patient survival in the basal PAM50 cancer subtype compared to normal and luminal subtypes. Further, across multiple cancer types, high ADM5  \n*Correspondence: Kevin P. Claffey [claffey@uchc.edu](claffey@uchc.edu)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nPhoenix","cbCaibZjRIvqAXMI","https://ap.wps.com/l/cbCaibZjRIvqAXMI","pdf",6225079,18,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Tumor microenvironment and vascular abnormalities\n# Keywords","[{\"question\":\"What is the main purpose of comparing normal and tumor endothelial cells in this study?\",\"answer\":\"To characterize how endothelial-cell populations differ between normal breast tissue and breast tumors, identify tumor endothelial subtypes, and uncover tumor-specific vascular therapeutic targets.\"},{\"question\":\"How were endothelial-cell subtypes and tumor-specific markers identified?\",\"answer\":\"Single-cell RNA-seq datasets were integrated, endothelial subsets were extracted using canonical marker expression, then cells were clustered and differentially expressed genes were determined between normal and tumor endothelial cells.\"},{\"question\":\"Which marker is highlighted as novel, and what clinical association is reported?\",\"answer\":\"ADM5 is presented as a novel tumor vascular marker enriched in tumor venules; high ADM5 expression is associated with reduced patient survival, including in certain treatment contexts and breast cancer subtypes.\"}]","Transcriptomic profiles from normal and tumor tissue samples reveal distinct venule populations and novel tumor endothelial cell markers in breast cancer - Research article summary | PDF",1790094045,45,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9dd662a232636df8fe418311ca6168eb.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c7db0acf0b064593b6e29cec56a93be.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6477bb768ca8499122385f92b1321074.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ded6adb7100ffa229d971b8b17086762.webp",980,1306]